Transition from fresh frozen plasma to solventdetergent plasma
- Slides: 6
Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks by Nicholas H. Saadah, Martin R. Schipperus, Johanna C. Wiersum-Osselton, Marian G. van Kraaij, Camila Caram-Deelder, Erik A. M. Beckers, Anja Leyte, Jan M. M. Rondeel, Karen M. K. de Vooght, Floor Weerkamp, Jaap Jan Zwaginga, and Johanna G. van der Bom haematol Volume 105(4): 1158 -1165 March 31, 2020 © 2020 by Ferrata Storti Foundation
Number and type of plasma units distributed to all Dutch hospitals between 2012 and 2017. Nicholas H. Saadah et al. Haematologica 2020; 105: 11581165 © 2020 by Ferrata Storti Foundation
Data flow diagram showing categorization of episodes into sub-cohorts for patients receiving plasma transfusion in (all or part of) 2010 to 2016. Nicholas H. Saadah et al. Haematologica 2020; 105: 11581165 © 2020 by Ferrata Storti Foundation
Blood product details for the different cohorts (episodes involving plasma transfusion). Nicholas H. Saadah et al. Haematologica 2020; 105: 11581165 © 2020 by Ferrata Storti Foundation
Blood product use prior to versus after the switch from fresh frozen plasma to solvent/detergent treated pooled plasma. Nicholas H. Saadah et al. Haematologica 2020; 105: 11581165 © 2020 by Ferrata Storti Foundation
Comparison of the number of transfusion reactions and transfusion reaction risk for fresh frozen plasma and solvent/detergent plasma using national hemovigilance data. Nicholas H. Saadah et al. Haematologica 2020; 105: 11581165 © 2020 by Ferrata Storti Foundation
